Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes
Clinical trial NCT00924105 · COMPLETED
Trial details
- NCT number
- NCT00924105
- Sponsor
- Cytos Biotechnology AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-11-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.